Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

KÜBRA ÇALIŞKAN

Doktor Öğretim Üyesi

Gazi Üniversitesi Eczacılık Fakültesi Eczacılık Meslek Bilimleri Bölümü

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Farmasotik Kimya
Articles 13 YÖKSİS 13 · OpenAlex 0 Total citations 344 h-index 7 · OpenAlex Q1 articles 10 Scopus · WoS Q1 10 Best field rank #82 / 206 Side field · top 39.8% Co-authors 37 5 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 12 + YÖKSİS · co-author record: 2
h-index 7 Percentile in Türkiye: 67 #988 of 2,186 at their university by h-index
i10-index
6
Total citations
344
Top 24% in Türkiye
Per article
24.6
FWCI
2.48
1.00 = world average
World top 1%
1
World top 10%
5

Most cited articles

  1. The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool 2022 world top 1% 125 citations
  2. Mercury chloride induced oxidative stress in human erythrocytes and the effect of vitamins C and E in vitro 2010 world top 10% 65 citations
  3. Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity 2012 world top 10% 60 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 2 articles (125 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
37
With an akaturk profile
16
Turkish institutions
5
Co-authored works
%100

Academic co-authors 16

  1. ERDEN BANOĞLU Profesör · Gazi Üniversitesi same university 12
  2. BURCU ÇALIŞKAN Profesör · Gazi Üniversitesi same university 10
  3. DENİZ LENGERLİ Doktor Öğretim Üyesi · Gazi Üniversitesi same university 5
  4. ECE AKHAN GÜZELCAN Öğretim Görevlisi (uygulamalı Birim) · Hacettepe Üniversitesi 3
  5. ESRA NALBAT Araştırma Görevlisi · Orta Doğu Teknik Üniversitesi 3
  6. ÖZGE AKBULUT ÇALIŞKAN Doktor Öğretim Üyesi · Başkent Üniversitesi 3
  7. AYŞEGÜL ÜNER Profesör · Hacettepe Üniversitesi 2
  8. BEYZANUR KOÇ Araştırma Görevlisi · Gazi Üniversitesi same university 2
  9. MERAL ÜNER Doktor Öğretim Üyesi · Hacettepe Üniversitesi 2
  10. SERCAN AKSOY Profesör · Hacettepe Üniversitesi 2
Show all (16)
  1. ERKAN KİRİŞ Doçent · Orta Doğu Teknik Üniversitesi 1
  2. MEHMET KARATAŞ Araştırma Görevlisi · Erzincan Binali Yıldırım Üniversitesi 1
  3. NUR BANU BAL Doçent · Gazi Üniversitesi same university 1
  4. SEZEN GÜNTEKİN ERGÜN Öğretim Görevlisi (uygulamalı Birim) · Hacettepe Üniversitesi 1
  5. YAHYA NURAL Profesör · Mersin Üniversitesi 1
  6. ZEHRA TUĞÇE GÜR MAZ Doçent · Gazi Üniversitesi same university 1

National collaboration 5 institutions

Within own university12 joint works · Gazi Üniversitesi

  1. Hacettepe Üniversitesi 5 works · 5 academics
  2. Orta Doğu Teknik Üniversitesi 4 works · 2 academics
  3. Başkent Üniversitesi 3 works · 1 academics
  4. Erzincan Binali Yıldırım Üniversitesi 1 works · 1 academics
  5. Mersin Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 21

OLIVER WERZ 5PAUL JORDAN 5RENGÜL ATALAY 3ÖZGÜR ŞAHİN 3Özge Saatci 3METİN ÇETİN 2MUSTAFA EMRE GEDİK 2Nathaniel Oberholtzer 2Shikhar Mehrotra 2Stefan Wiemann 2Arooj BakhtChaemin LimDilara KoçEsra SadakMERTKAYA ARASMESUT MUYANMert Kaya ArasPeri BeşaretPhilipp DahlkeSridhar VempatiSÜMEYYE TURANLI

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 1 articles
OpenAlex citation percentile
Top 1%1
Top 10%3
Avg · n 11 %72.5
Other counts

Scopus (SJR)

  • Excluding abstracts 12 Q1 9 Q2 2 Q4 1
  • YÖKSİS rows 13

WoS (JCR)

  • Excluding abstracts 12 Q1 9 Q2 2 Q3 1
  • YÖKSİS rows 13

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

13articles

Journals with publications

8 journals

Narrow down

Scopus (SJR)
Q110 Q22 Q30 Q41
WoS (JCR)
Q110 Q22 Q31 Q40
TR Index
1articles

Article list

  1. 2025 Phenyl-benzyl-ureas with pyridazinone motif: Potent soluble epoxide hydrolase inhibitors with enhanced pharmacokinetics and efficacy in a paclitaxel-induced neuropathic pain model European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2025.117510 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 91.6%
  2. 2025 Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.108204 YÖKSİS SJR Q1 JCR Q1 OpenAlex 62.5%
  3. 2025 Harnessing structure-activity relationships to repurpose the FLAP inhibitor BRP-7 into potent and selective sEH inhibitors Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.108997 YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.1%
  4. 2025 Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.108644 YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.6%
  5. 2025 Synthesis, molecular docking, and in vitro evaluation of 2,4-dichlorobenzylamide derivatives as soluble epoxide hydrolase (sEH) inhibitors Organic Communications DOI 10.25135/acg.oc.195.2507.3595 YÖKSİS TR Index SJR Q4 JCR Q3 OpenAlex 16.0%
  6. 2024 Abstract LB275: Reactivation of mitotic arrest upon targeting TACC3 restores immunogenic cell death and T-DM1 response in HER2-positive breast cancer Cancer Research DOI 10.1158/1538-7445.AM2024-LB275 YÖKSİS SJR Q1 JCR Q1
  7. 2024 Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer Cancer Research DOI 10.1158/0008-5472.CAN-23-2812 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.3%
  8. 2024 Tirbanibulin (KX2-391) analog KX2-361 inhibits botulinum neurotoxin serotype A mediated SNAP-25 cleavage in pre- and post-intoxication models in cells DRUG DEVELOPMENT RESEARCH DOI 10.1002/ddr.22248 YÖKSİS SJR Q2 JCR Q1 OpenAlex 66.4%
  9. 2023 Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors ACS Omega DOI 10.1021/acsomega.2c06936 YÖKSİS SJR Q2 JCR Q2 OpenAlex 77.5%
  10. 2022 Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity ACS OMEGA DOI 10.1021/acsomega.2c03405 YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.5%
  11. 2022 The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool EXPERT OPINION ON DRUG DISCOVERY DOI 10.1080/17460441.2022.2129613 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.2%
  12. 2021 Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2021.113489 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.2%
  13. 2018 Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents Journal of Enzyme Inhibition and Medicinal Chemistry DOI https://www.tandfonline.com/doi/full/10.1080/14756366.2018.1504041 YÖKSİS SJR Q1 JCR Q1

← Back to academicians